- A Summons with Cease and Desist Order was issued by the Philippine Food and Drug Administration (FDA) against pharmaceutical giant Sanofi Pasteur Inc.
- The FDA called out the pharmaceutical company for airing television and radio advertisements of its dengue vaccine, Dengvaxia
- The airing of the advertisement is in violation of Administrative Order No. 65 s. 1989, prohibiting advertisement in any form of prescription or ethical drug
A Summons with Cease and Desist Order was issued by the Philippine Food and Drug Administration (FDA) against pharmaceutical giant Sanofi Pasteur Inc. for airing television and radio advertisements of its dengue vaccine, Dengvaxia.
On its official Facebook page, the Department of Health (DOH) disclosed that the FDA’s Center for Drug Regulation and Research has monitored the airing of the advertising materials on dengue vaccination, and has also reported the unauthorized promotion of dengue vaccine in the malls.
In the Summons issued by FDA last December 13, 2016, Sanofi was directed to cease and desist from disseminating advertisements for Dengvaxia in any form of mass or social media. To note, the airing of the advertisement is in violation of Administrative Order No. 65 s. 1989 prohibiting advertisement in any form of prescription or ethical drug, it was disclosed.
Sanofi was also directed to stop activities promoting and marketing the vaccine.
As of December 15, 2016, on the other hand, the company has failed to comply with FDA’s directive to take down the said advertisements.